CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DiaSys Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DiaSys Corporation
21 W Main St
Phone: (302) 636-5400p:302 636-5400 WATERBURY, CT  06702-2013  United States Ticker: DYXCDYXC

This company ceased filing statements with the SEC on 3/11/2008.

Business Summary
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20076/30/2007YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Financial Officer MorrisSilverman 80 10/1/2007 11/12/2002
President, Interim Chief Executive Officer Frederic H.Neikrug 68 7/13/2007 7/13/2007
Secretary, Director Robert M.Wigoda 57 1/1/2003 1/1/2003
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 10 (As of 6/30/2007)
Outstanding Shares: 25,721,822 (As of 9/30/2007)
Shareholders: 150
Stock Exchange: OTC
Federal Tax Id: 061339248
Fax Number: (302) 636-5454
Email Address: diasys@diasyscorp.com


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 5, 2021